Ariela Noy

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 30 papers. Top paper: “Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma”.

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

Journal of Clinical Oncology(2020)10.1200/jco.20.00303

N/A

5.0DataRank · unranked

152 citations

Kieron Dunleavy, Jeremy S. Abramson, Bayard L. Powell, Brian K. Link, Prapti A. Patel +19 more

A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas

Blood(2021)10.1182/blood.2021013379

N/A

4.9DataRank · unranked

180 citations

Paola Ghione, Eric D. Jacobsen, Jia Ruan, Jonathan H. Schatz, Sarah Noor +31 more

Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trial

The Lancet Haematology(2021)10.1016/s2352-3026(21)00307-0

N/A

3.8DataRank · unranked

110 citations

Anthony R Mato, Ahmet Dogan, Venkatraman E Seshan, Erel Joffe, Kelsey Flaherty +41 more

Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)

Blood(2020)10.1182/blood.2019003959

N/A

2.1DataRank · unranked

70 citations

Joseph A. Sparano, Amy Chadburn, Erin Reid, Richard F. Ambinder, Eric R. Siegel +13 more

Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma

European Journal of Cancer(2020)10.1016/j.ejca.2019.12.006

N/A

1.3DataRank · unranked

29 citations

Fushen Sha, Anna Alperovich, Ai Ni, Katy Smith, Zhitao Ying +20 more

Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial

The Lancet Haematology(2023)10.1016/s2352-3026(23)00157-6

N/A

0.847DataRank · unranked

32 citations

Page C. Moore, Milan Bimali, Jeanette Y. Lee, Michelle A. Rudek, Amy Chadburn +22 more

Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

Blood(2022)10.1182/blood.2022016534

N/A

0.673DataRank · unranked

88 citations

Kostiantyn Dreval, Daniela S. Gerhard, Laura K. Hilton, Jeremy S. Abramson, Richard F. Ambinder +63 more

TP53mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy

Blood Advances(2023)10.1182/bloodadvances.2023009953

N/A

0.505DataRank · unranked

28 citations

Nivetha Ganesan, Zachary D. Epstein‐Peterson, Alison J. Moskowitz, Robert Stuver, Catherine Maccaro +27 more

Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma

Haematologica(2020)10.3324/haematol.2019.243386

N/A

0.425DataRank · unranked

16 citations

Jeannette Y. Lee, Lawrence D. Kaplan, Juan Carlos Ramos, Richard F. Ambinder, William Wachsman +8 more

Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma

Blood Cancer Journal(2022)10.1038/s41408-022-00620-w

N/A

0.291DataRank · unranked

5 citations

Michelle Okwali, Anna Alperovich, Philip Caron, Lorenzo Falchi, Audrey Hamilton +22 more

Patients with Castleman disease report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccination

Blood Neoplasia(2024)10.1016/j.bneo.2024.100002

N/A

0.180DataRank · unranked

2 citations

Sheila K. Pierson, Caoilfhionn M Connolly, Mayan Teles, Dorry L. Segev, William A. Werbel +6 more

Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024014263

N/A

0.113DataRank · unranked

1 citations

Parastoo B. Dahi, Farhad Khimani, Andrei R. Shustov, Mazyar Shadman, Jia Ruan +19 more

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

Blood Cancer Journal(2024)10.1038/s41408-024-01148-x

N/A

0DataRank · unranked

3 citations

Efrat Luttwak, Alfredo Rivas‐Delgado, Helen Irawan, Alexander P. Boardman, Philip Caron +26 more

CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas

Blood Neoplasia(2024)10.1016/j.bneo.2024.100031

N/A

0DataRank · unranked

1 citations

Kurt S. Bantilan, Erel Joffe, M. Lia Palomba, Ariela Noy, Philip Caron +12 more

DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features

Blood Cancer Discovery(2025)10.1158/2643-3230.bcd-24-0240

N/A

0DataRank · unranked

4 citations

Carlos A. García‐Prieto, Kostiantyn Dreval, Laura K. Hilton, Jeremy S. Abramson, Nancy L. Bartlett +34 more

Mutational and copy number analysis at diagnosis and relapse of mantle cell lymphoma

Haematologica(2025)10.3324/haematol.2024.286813

N/A

0DataRank · unranked

1 citations

Manik Uppal, Serena Zheng, Kurt S. Bantilan, Connie Lee Batlevi, Zachary D. Epstein‐Peterson +21 more

120 | DETECTION OF INTRATUMORAL MICROORGANISMS AND THEIR IMPACT ON OUTCOMES IN UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA

Hematological Oncology(2025)10.1002/hon.70093_120

N/A

0DataRank · unranked

0 citations

Chad Vanderbilt, Teng Fei, Ticiane Henriques Santa Rita, A. Rivas Delgado, Annie Qiu +31 more

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

Blood Cancer Journal(2020)10.1038/s41408-020-00340-z

N/A

0DataRank · unranked

203 citations

Fushen Sha, Anna Alperovich, Ai Ni, Katy Smith, Zhitao Ying +20 more

Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study

Research Square(2025)10.21203/rs.3.rs-7607922/v1

N/A

0DataRank · unranked

0 citations

Brian L. Egleston, Zachary AK Frosch, Ralphael Steiner, Ariela Noy, Veronica Carvajal +42 more

Rosai-Dorfman Disease—Utility of 18F-FDG PET/CT for Initial Evaluation and Follow-up

Clinical Nuclear Medicine(2020)10.1097/rlu.0000000000003014

N/A

0DataRank · unranked

42 citations

Reiko Nakajima, Mariko Yabe, Ahmet Doǧan, Gary A. Ulaner, Joachim Yahalom +4 more

Excellent Outcomes with Surgery or Radiotherapy in the Management of Castleman Disease Including a Case of Oligocentric Disease

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.05.002

N/A

0DataRank · unranked

22 citations

Joanna C. Yang, Karen Chau, Ariela Noy, Joachim Yahalom, Thomas H. Beckham

Primary lymphoma of the breast: A report of two cases

Clinical Imaging(2020)10.1016/j.clinimag.2020.08.008

N/A

0DataRank · unranked

18 citations

Donna D’Alessio, Andrew C. Kim, Elizabeth A. Morris, April Chiu, Ariela Noy +1 more

Predictors of Major Hemorrhage After Spleen Core Biopsy in Cancer Patients

Journal of Vascular and Interventional Radiology(2022)10.1016/j.jvir.2022.06.002

N/A

0DataRank · unranked

9 citations

N. Ari Wijetunga, Joseph P. Erinjeri, Ariela Noy, Amy R. Deipolyi, Henry Kunin

Long‐term outcomes of patients with limited‐stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era

British Journal of Haematology(2022)10.1111/bjh.18590

N/A

0DataRank · unranked

2 citations

Brandon S. Imber, Michelle Okwali, Paul A. Hamlin, Anita Kumar, Oscar Lahoud +11 more

Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma

British Journal of Haematology(2023)10.1111/bjh.19178

N/A

0DataRank · unranked

7 citations

Ariela Noy, Santosha A. Vardhana, Andrew D. Zelenetz, Alison J. Moskowitz, Robert Stuver

Molecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma with CREBBP or EP300 mutations: an open label phase II study

Leukemia & lymphoma/Leukemia and lymphoma(2023)10.1080/10428194.2022.2164194

N/A

0DataRank · unranked

9 citations

Ariela Noy, David J. Straus, Matthew J. Matasar, Craig H. Moskowitz, Venkatraman Seshan +6 more

Retrospective characterization of nodal marginal zone lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022009587

N/A

0DataRank · unranked

8 citations

Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip Caron +24 more

Factors Affecting Diagnostic Yield of Lesional Bone Biopsy in Hematologic Malignancy Patients

CardioVascular and Interventional Radiology(2023)10.1007/s00270-023-03594-9

N/A

0DataRank · unranked

2 citations

Majid Maybody, Ahmed Aly, Elena N. Petre, Ernesto Santos, Ariela Noy +6 more

Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R

Blood Advances(2023)10.1182/bloodadvances.2023010223

N/A

0DataRank · unranked

0 citations

Kieron Dunleavy, Jeremy S. Abramson, Brian K. Link, Bayard L. Powell, Christopher Melani +10 more

Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis

Haematologica(2024)10.3324/haematol.2023.284179

N/A

0DataRank · unranked

8 citations

Zachary D. Epstein‐Peterson, Nivetha Ganesan, Timothy Pak, Tiffany Chang, Phuong Dao +21 more